Study Stopped
Low recruitment rate.
Anterior Defect Correction With Mesh Plus Treatment of Stress Incontinence With Transobturator or Transvaginal Approach
A Comparison in Terms of Efficacy and Safety Between Transobturator and Transvaginal Tape Performed at the Same Time of Anterior Defect Correction With Mesh
1 other identifier
interventional
15
1 country
1
Brief Summary
The incidence of anterior pelvic defect in women is estimated about 10% and it may be often associated to urinary stress incontinence. To date the correction of anterior defects with the use of graft material inserted with transobturator approach has become of large use. Moreover, given the frequent association of urinary stress incontinence to anterior defect, in most of cases it becomes necessary to perform at the same time an anti-incontinence procedure, i.e. a sub-urethral sling positioning. Based on these considerations the aim of this trial will be to compare two different approach for sub-urethral sling positioning, transobturator and transvaginal tape (TOT and TVT) performed in association to transobturator correction of anterior defect with mesh in terms of efficacy and safety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
August 28, 2008
CompletedFirst Posted
Study publicly available on registry
August 29, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2013
CompletedApril 8, 2013
April 1, 2013
5 years
August 28, 2008
April 5, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Objective/subjective symptoms improvements
12 months
Secondary Outcomes (6)
Intra-operative complication rate
one day
Postoperative complications rate
12 months
Failure rate
12 months
Recurrence rate
12 months
Quality of life
12 months
- +1 more secondary outcomes
Study Arms (2)
1
EXPERIMENTALTransobturatory correction of anterior defect plus TOT
2
ACTIVE COMPARATORLongitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage. Small incision sites at sovrapubic level. Bilateral retropubic insertion of mesh by means of mono-use needle.
Interventions
Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage. Small incision sites in the femoral/pelvic fold. Bilateral transobturator insertion of mesh by means of mono-use needle
Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage. Small incision sites at sovrapubic level. Bilateral retropubic insertion of mesh by means of mono-use needle.
Eligibility Criteria
You may qualify if:
- Cystocele
- Genuine stress urinary incontinence by self report, examination and test
- Urethral hypermobility
- Eligible for both surgical procedures
- Ambulatory
You may not qualify if:
- Pregnancy
- \<12 months post-partum
- Systemic disease and/or drugs known to affect bladder function
- Current chemotherapy or radiation therapy
- Urethral diverticulum, augmentation cytoplasty, or artificial sphincter
- Recent pelvic surgery
- Previous pelvic or anti-incontinence surgery
- History of severe abdominopelvic infections
- Known extensive abdominopelvic adhesions
- Detrusor instability and/or intrinsic sphincter dysfunction
- Other gynaecologic pathologies (eg, fibroids, ovarian cysts)
- BMI \>30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
"Pugliese" Hospital
Catanzaro, Catanzaro, 88100, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefano Palomba, MD
Chair of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro
- STUDY CHAIR
Fulvio Zullo, MD
Chair of Obstetrics and Gynecology, University "Magna Graecia" of Catanzaro
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
August 28, 2008
First Posted
August 29, 2008
Study Start
February 1, 2008
Primary Completion
February 1, 2013
Last Updated
April 8, 2013
Record last verified: 2013-04